Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EVAX

Evaxion Biotech AS (EVAX)

Evaxion Biotech AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EVAX
DateTimeSourceHeadlineSymbolCompany
01/15/20257:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
01/15/20257:00AMGlobeNewswire Inc.Evaxion completes dosing in phase 2 trial with personalized cancer vaccine EVX-01NASDAQ:EVAXEvaxion Biotech AS
01/14/20253:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
01/14/20253:05PMGlobeNewswire Inc.Evaxion announces completion of ADS ratio changeNASDAQ:EVAXEvaxion Biotech AS
01/10/20257:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
01/10/20257:00AMGlobeNewswire Inc.Evaxion announces extension to January 14, 2025, of plan to implement ADS ratio changeNASDAQ:EVAXEvaxion Biotech AS
01/07/20258:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/30/20247:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/30/20247:00AMGlobeNewswire Inc.Evaxion announces plan to implement ADS ratio changeNASDAQ:EVAXEvaxion Biotech AS
12/26/20243:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/17/20244:09PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
12/17/20247:16AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/17/20247:00AMGlobeNewswire Inc.Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equityNASDAQ:EVAXEvaxion Biotech AS
12/12/20247:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/12/20247:00AMGlobeNewswire Inc.Evaxion establishes new AI-derived precision cancer vaccine conceptNASDAQ:EVAXEvaxion Biotech AS
12/09/20248:01AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/09/20247:00AMGlobeNewswire Inc.Evaxion announces 2025 milestones reflecting continued strong strategy executionNASDAQ:EVAXEvaxion Biotech AS
12/05/20243:53PMEdgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
12/03/20245:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
12/02/20247:00AMGlobeNewswire Inc.Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology CongressNASDAQ:EVAXEvaxion Biotech AS
11/18/20243:30PMEdgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVAXEvaxion Biotech AS
11/13/20248:00AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/13/20247:00AMGlobeNewswire Inc.Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listingNASDAQ:EVAXEvaxion Biotech AS
11/13/20246:30AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/13/20246:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
11/12/20247:00AMGlobeNewswire Inc.Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1NASDAQ:EVAXEvaxion Biotech AS
10/31/20249:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/31/20247:00AMGlobeNewswire Inc.Evaxion announces business update and third quarter 2024 financial resultsNASDAQ:EVAXEvaxion Biotech AS
10/28/20248:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/28/20247:00AMGlobeNewswire Inc.Evaxion to announce business update and third quarter 2024 financial results on October 31NASDAQ:EVAXEvaxion Biotech AS
 Showing the most relevant articles for your search:NASDAQ:EVAX

Your Recent History

Delayed Upgrade Clock